Fine, R. E., Gilmore, R. C., Tomkovich, K. R., Dietz, J. R., Berry, M. P., Hernandez, L. E., Columbus, K. S., Seedman, S. A., Fisher, C. S., Han, L. K., Manahan, E. R., Hicks, R. D., Vaidya, R. P., Curcio, L. D., Sevrukov, A. B., Kenler, A. S., Taback, B., Chen, M., Miller, M. E., … Boolbol, S. K. (2024). Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology, 31(11), 7273–7283. https://doi.org/10.1245/s10434-024-16181-0

Asiimwe, A. C., Marin, M. P., & Salvatore, M. (2024). Breast Collagen Organization: Variance by Patient Age and Breast Quadrant. Diagnostics, 14(16), 1748. https://doi.org/10.3390/diagnostics14161748

Switalla, K. M., Boughey, J. C., Dimitroff, K., Yau, C., Ladores, V., Yu, H., Tchou, J., Golshan, M., Ahrendt, G., Postlewait, L. M., Piltin, M., Reyna, C. R., Matsen, C. B., Tuttle, T. M., Wallace, A. M., Arciero, C. A., Lee, M. C., Tseng, J., Son, J., … Mukhtar, R. A. (2024). Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-024-15792-x

McCarthy, A. M., Ehsan, S., Hughes, K. S., Lehman, C. D., Conant, E. F., Kontos, D., Armstrong, K., & Chen, J. (2024). Feasibility of risk assessment for breast cancer molecular subtypes. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07404-9

Chen, Y., Zhang, A., Lu Wang, M., Black, G. G., Zhou, G., & Otterburn, D. M. (2024). Using a Machine Learning Approach to Predict the Need for Elective Revision and Unplanned Surgery after Implant-based Breast Reconstruction. Plastic and Reconstructive Surgery - Global Open, 12(3), e5542. https://doi.org/10.1097/gox.0000000000005542

Bardia, A., Pusztai, L., Albain, K., Ciruelos, E. M., Im, S.-A., Hershman, D., Kalinsky, K., Isaacs, C., Loirat, D., Testa, L., Tokunaga, E., Wu, J., Dry, H., Barlow, W., Kozarski, R., Maxwell, M., Harbeck, N., & Sharma, P. (2024). TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241248336

Sanft, T., Harrigan, M., McGowan, C., Cartmel, B., Zupa, M., Li, F.-Y., Ferrucci, L. M., Puklin, L., Cao, A., Nguyen, T. H., Neuhouser, M. L., Hershman, D. L., Basen-Engquist, K., Jones, B. A., Knobf, T., Chagpar, A. B., Silber, A., Tanasijevic, A., Ligibel, J. A., & Irwin, M. L. (2023). Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal of Clinical Oncology, 41(34), 5285–5295. https://doi.org/10.1200/jco.23.00871

Capaccione, K., Desperito, E., Asiimwe, A. C., & Salvatore, M. (2024). Can Hounsfield units on chest CT characterize breast nodules as cystic or solid? Translational Breast Cancer Research, 5, 6–6. https://doi.org/10.21037/tbcr-23-34

Basu, A., Umashankar, S., Musthafa, M., Jones, T., Blevins, K., Brown, T., Heditsian, D., Parker, B., Brain, S., Simmons, C., Hieken, T. J., Ruddy, K., Mainor, C., Tevis, S., Blaes, A., Rugo, H. S., Dunn, I., Melisko, M., Esserman, L., & Hershman, D. L. (2023). 374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial. Annals of Oncology, 34, S332–S333. https://doi.org/10.1016/j.annonc.2023.09.552

Dagi, A. F., Marano, A. A., & Rohde, C. H. (2023). Nipple Sensation Loss after Oncoplastic Breast Reduction. Plastic & Reconstructive Surgery, 152(4), 766e–767e. https://doi.org/10.1097/prs.0000000000010672

Cannioto, R. A., Attwood, K. M., Davis, E. W., Mendicino, L. A., Hutson, A., Zirpoli, G. R., Tang, L., Nair, N. M., Barlow, W., Hershman, D. L., Unger, J. M., Moore, H. C. F., Isaacs, C., Hobday, T. J., Hortobagyi, G. N., Gralow, J. R., Albain, K. S., Budd, G. T., & Ambrosone, C. B. (2023). Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer. JAMA Network Open, 6(5), e2311673. https://doi.org/10.1001/jamanetworkopen.2023.11673

Baskota, S. U., Qazi, D., Chandra, A., & Vohra, P. (2022). Comprehensive Review of Metastatic Breast Carcinoma in Cytology Specimens. Journal of Molecular Pathology, 3(4), 293–306. https://doi.org/10.3390/jmp3040025

Prigoff, J., Staebler, M., Rao, R., Taback, B., Wiechmann, L., & Accordino, M. K. (2022). The impact of COVID-19 on breast surgery during the height of the New York City pandemic. Annals of Breast Surgery, 6, 29–29. https://doi.org/10.21037/abs-20-55

Vikas, P., Korde, L. A., Somerfield, M. R., & Hershman, D. L. (2022). Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A. JCO Oncology Practice, 18(9), 649–651. https://doi.org/10.1200/op.22.00284

Brown, A., Buss, E. J., Chin, C., Liu, G., Lee, S., Rao, R., Taback, B., Wiechmann, L., Horowitz, D., Choi, J. C., Katz, L. M., & Connolly, E. P. (2022). Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.788213

Korde, L. A., Somerfield, M. R., & Hershman, D. L. (2022). Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology, 40(15), 1696–1698. https://doi.org/10.1200/jco.22.00503